|
COG1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.44970000448552E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.73659999999476E-05 |
| Normal-vs-Stage2 |
8.976400E-02 |
| Normal-vs-Stage3 |
9.777200E-03 |
| Normal-vs-Stage4 |
8.383700E-02 |
| Stage1-vs-Stage2 |
8.669000E-01 |
| Stage1-vs-Stage3 |
4.443800E-01 |
| Stage1-vs-Stage4 |
4.225000E-01 |
| Stage2-vs-Stage3 |
5.037000E-01 |
| Stage2-vs-Stage4 |
4.406200E-01 |
| Stage3-vs-Stage4 |
8.067200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.34519999975369E-07 |
| Normal-vs-AfricanAmerican |
1.184490E-03 |
| Normal-vs-Asian |
2.322600E-01 |
| Caucasian-vs-AfricanAmerican |
7.900400E-01 |
| Caucasian-vs-Asian |
6.542000E-01 |
| AfricanAmerican-vs-Asian |
5.670000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.94250000038221E-07 |
| Normal-vs-Female |
3.74720000000384E-05 |
| Male-vs-Female |
4.274400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.782000E-02 |
| Normal-vs-Extreme_Weight |
1.503800E-03 |
| Normal-vs-Obese |
3.975900E-04 |
| Normal-vs-Extreme_Obese |
2.999400E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.652000E-01 |
| Normal_Weight-vs-Obese |
4.529800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.309200E-01 |
| Extreme_Weight-vs-Obese |
5.916600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.926400E-01 |
| Obese-vs-Extreme_Obese |
5.826000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.460370E-03 |
| Normal-vs-Age(41-60Yrs) |
1.20930043756573E-10 |
| Normal-vs-Age(61-80Yrs) |
1.363590E-02 |
| Normal-vs-Age(81-100Yrs) |
9.070200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.025800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.224100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.972020E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.68839999999638E-05 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.008200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.576800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.84630044165158E-10 |
| Normal-VS-Type2 PRCC |
9.583400E-03 |
| Normal-VS-KIRP CIMP |
9.980600E-01 |
| Normal-VS-Unclassified PRCC |
5.119100E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.296780E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.398200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.891200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.055210E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.975600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.441900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.178700E-03 |
| Normal-vs-N1 |
1.569660E-02 |
| Normal-vs-N2 |
1.991850E-01 |
| N0-vs-N1 |
2.716200E-01 |
| N0-vs-N2 |
3.845400E-01 |
| N1-vs-N2 |
8.318800E-01 |
|
|
